Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...
Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...
Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...
As rheumatologists prepare for EULAR 2026, Clinical Trials Arena takes a look at the most promising drugs in late-stage development for PsA.
Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...
This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.
A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...
Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...